NEW YORK (GenomeWeb News) — Oxford Gene Technology has licensed its Southern array patents to Applied Microarrays, OGT said today.
The IP comprises the fundamental patents enabling companies to manufacture and market oligonucleotide microarrays, and will allow Applied Microarrays to fabricate, market, and distribute the CodeLink line it acquired in May from GE Healthcare.
AMI, a 1-year-old firm headed by a former Motorola Life Sciences researcher, also gets OEM rights to manufacture custom arrays for third parties under their own brand name.
The license will remain valid for the patents’ lifetime.
Financial details were not disclosed.